Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Fentanyl
Effentora
Not routinely available
SMC (510/08)
29/03/2023
Indication
Breakthrough pain in adults with cancer. See link to SMC advice for full details of restriction.
Therapeutic Area
Central nervous system
Status Description
Not routinely available as local clinical experts do not wish to add the medicine to the formulary at this time or there is a local preference for alternative medicines
Formulation
100, 200, 400, 600 and 800 microgram buccal tablet
Comments
-